COVID-19-affected patients with acute respiratory failure present a severe hypercoagulability rather than consumptive coagulopathy [20], with a concurrent massive elevation of von Willebrand Factor [21] towards massive endothelial stimulation and damage with release of von Willebrand Factor from Weibel–Palade bodies. This evidence concerns the gene VWF and thrombophilia.